SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001096906-22-002280
Filing Date
2022-09-19
Accepted
2022-09-19 16:14:42
Documents
17
Period of Report
2022-09-15
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 AXIM BIOTECHNOLOGIES, INC. - FORM 8-K SEC FILING axim-20210915.htm   iXBRL 8-K 18654
2 SEPTEMBER 15, 2022, LICENSE AND DISTRIBUTION AGREEMENT BY AND BETWEEN AXIM BIOTE axim_ex10z1.htm EX-10.1 108655
3 PRESS RELEASE axim_ex99z1.htm EX-99.1 13703
8 IMAGE axim8k_1.jpg GRAPHIC 38710
  Complete submission text file 0001096906-22-002280.txt   389167

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT axim-20210915_def.xml EX-101.DEF 1842
5 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT axim-20210915_lab.xml EX-101.LAB 20742
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT axim-20210915_pre.xml EX-101.PRE 13772
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT axim-20210915.xsd EX-101.SCH 2513
10 EXTRACTED XBRL INSTANCE DOCUMENT axim-20210915_htm.xml XML 2444
Mailing Address 6191 CORNERSTONE COURT, E SUITE 114 SAN DIEGO CA 92121
Business Address 6191 CORNERSTONE COURT, E SUITE 114 SAN DIEGO CA 92121 (212) 751-0001
AXIM BIOTECHNOLOGIES, INC. (Filer) CIK: 0001514946 (see all company filings)

IRS No.: 274092986 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-54296 | Film No.: 221250749
SIC: 2834 Pharmaceutical Preparations